The history of the erectile dysfunction drug presents a intricate picture for investors. While the initial introduction generated significant returns, the end of its exclusive rights opened the avenue to generic https://socialrus.com/story25251136/the-copyright-and-the-pharmaceutical-industry-a-volatile-bet